QNTM QUANTUM BIOPHAR

NASDAQ
$1.52

QUANTUM BIOPHAR (QNTM) SEC Filings

Everything QNTM has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

15 filings
Date Form Filing
6-K Earnings Release · Executive Change · Material Agreement · Other
6-K Acquisition Disposition · Capital Raise · Earnings Release
6-K Capital Raise · Other
6-K Other
6-K Other Reg Fd
6-K Material Agreement
SCHEDULE 13G/A
6-K Executive Change
6-K Capital Raise · Earnings Date Announcement · Earnings Release · Executive Change · Material Agreement · Other
6-K
6-K Investor Presentation
6-K/A
6-K/A
6-K/A
6-K Delisting

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.